FDA grants full approval to new Alzheimer’s drug ...Middle East

The Food and Drug Administration on Thursday granted full approval to Eisai’s and Biogen’s Alzheimer’s drug Leqembi, or lecanemab, marking the first drug in the class to receive the designation. Nationally, Alzheimer’s disease affects an estimated 6.7 million people aged 65 and older. Black people are twice as likely to develop dementia than white people, and […] The post FDA grants full approval to new Alzheimer’s drug appeared first on Roll Call.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA grants full approval to new Alzheimer’s drug )

Also on site :

• On the record: Hubbard
• ForexLive Asia-Pacific FX news wrap: Oil spike on talk of Israel preparing attack on Iran
• CNN Confession: Jake Tapper Admits Conservative Media Was Right About Biden’s Cognitive Decline